The Stock Picker’s Guide To Reckitt Benckiser Group Plc

A structured analysis of Reckitt Benckiser Group Plc (LON:RB).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Successful investors use a disciplined approach to picking stocks, and checklists can be a great way to make sure you’ve covered all the bases.

In this series I’m subjecting companies to scrutiny under five headings: prospects, performance, management, safety and valuation. How does Reckitt Benckiser (LSE: RB) (NASDAQOTH: RBGLY.US) measure up?

1. Prospects

Consumer staples are a classic defensive sector.  When the FTSE 100 index halved during the financial crash, RB’s shares lost just 9%.

In recent years, RB has focused on growing its higher-margin health and hygiene brands like Durex and Neurofen, rather than lower-margin home-care products, though the distinction can be obscure. It recently moved into vitamins and health supplements with a £1.4bn US acquisition.

RB is a global business selling in 200 countries.  Rapid growth in emerging markets mean these now contribute nearly 40% of sales, and will receive an increasing proportion of RB’s capital spending over the next few years.

Its pharmaceuticals business still contributes a quarter of sales but is suffering from generic competition to its main product, suboxone.

2. Performance

RB has an impeccable record of rising sales, operating profit, earnings and dividends since at least 2005. Over that time operating margins have broadly strengthened, from around 20% to 25%. However, return on equity has followed the reverse trend due to acquisitions and capital investments.

Dividend cover has tracked down from 2.5 times to just under 2, but is still acceptable.

3. Management

A lifelong employee, Rakesh Kapoor succeeded as CEO in 2011 and has been responsible for RB’s healthcare and emerging markets focus.

The Benckiser family still own 10% and nominate one director.

4. Safety

Net gearing is a modest 40% and interest cover is massive. Funding is helped by getting better terms of trade from suppliers than customers receive, which means RB can run on negative working capital like supermarkets do.

Operations are highly cash generating, with surplus funds spent on acquisitions and share repurchases in recent years. There is a small pension surplus.

5. Valuation

RB’s historic price-to-earnings (P/E) ratio of 18, falling to 16 on forecast earnings, is at a discount to Unilever‘s 20 and 18 respectively. Much of the discount is due to the drag of RB’s pharmaceuticals business, and a disposal might eliminate it.

Though the sector has been buoyed by investors seeking safe yields, perhaps surprisingly RB’s P/E has often been higher, and its yield lower than the current 3%.


RB’s defensive qualities and safe dividend make it an attractive cornerstone share. It has been catching-up in emerging markets, though its pharmaceuticals business is a headache.

If you’re looking for other cornerstone shares for your portfolio, I recommend you have a look at ‘Five Shares to Retire On‘, an exclusive report from the Motley Fool.  It describes five companies with dominant market positions, strong balance sheets and robust cash flow that could easily form the core of your portfolio. You can download it by clicking here — it’s free.

> Tony owns shares in Reckitt Benckiser and Unilever. The Motley Fool has recommended shares in Unilever.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Mature black couple enjoying shopping together in UK high street
Investing Articles

How much must I invest in Tesco shares to earn income of £1,000 a year in 2024?

Tesco shares have given investors a winning combination of dividend income and share price growth lately. Should I buy them?

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Should I sell underperforming Fundsmith Equity or can Terry Smith beat the world again?

Terry Smith's investment vehicle Fundsmith Equity is heading for a second year of underperformance. Is it time to bail out?

Read more »

Shot of a young Black woman doing some paperwork in a modern office
Investing Articles

2 quality growth stocks I’m looking to buy in December

Stephen Wright thinks two growth stocks could be great investments for 2024. One is a FTSE 100 conglomerate, the other…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Does today’s beaten down Scottish Mortgage share price make it a no-brainer buy?

The crashing Scottish Mortgage share price has marred many a portfolio. Now there's talk of a recovery. Am I in?

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

If I could only buy 1 more FTSE income stock in December, I’d grab this ultra-high-yielder

I think I can afford to buy one more FTSE 100 income stock before the end of the year. My…

Read more »

Abstract 3d arrows with rocket
Investing Articles

I think these are my best growth shares to buy with £1,000

Jon Smith talks through some shares to buy that he likes for next year, with a particular focus on retail…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

2 terrific cheap shares I’d snap up before it’s too late!

Our writer wants to capitalise on cheap shares now before any potential market rally and identifies a couple of stocks…

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

While the US stock market booms, the FTSE 100 lags behind. Or does it?

In November, global stock markets had their best month in over three years. Meanwhile, the UK's Footsie keeps falling further…

Read more »